SCHEMBL6380931

SCHEMBL6380931

COc1nccc2cc(C(C)C)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.43
ACHE P22303 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.39
RIOK2 Q9BVS4 4/20 0.38
GSK3A P49840 3/20 0.38
AURKA O14965 1/20 0.38
DAPK3 O43293 1/20 0.38
JAK2 O60674 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
ABL1 P00519 1/20 0.38
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
CSF1R P07333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13443769 0.79 TRPA1 (0.49) TRPA1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL10057582 0.79 CYP2A6 (0.50) TRPA1ACHEL3MBTL1GSK3AAURKA
SCHEMBL31255993 0.79 TRPA1 (0.44) TRPA1ACHEL3MBTL1CYP1A2CYP3A4
SCHEMBL10024935 0.79 LMNA (0.41) TRPA1ACHEL3MBTL1MAPTGSK3A
SCHEMBL6382617 0.79 TRPA1 (0.44) TRPA1ACHEL3MBTL1CYP1A2CYP3A4
SCHEMBL6389633 0.79 TRPA1 (0.62) TRPA1ACHECYP1A2CYP3A4CYP2D6
SCHEMBL113390 0.77 TRPA1 (0.43) TRPA1L3MBTL1CYP1A2CYP3A4CYP2D6
SCHEMBL18318359 0.77 PLAU (0.47) TRPA1ACHEL3MBTL1CYP1A2CYP3A4
SCHEMBL22170802 0.77 LMNA (0.40) ACHEL3MBTL1CYP3A4MAPTGSK3A
SCHEMBL15195532 0.77 TNF (0.46) TRPA1CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4215525-A1 PIPERAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2023-07-26 EP disclosed
EP-2033654-B1 Process for resolving a mixture of alkyl ester enantiomers using an enzyme BRISTOL MYERS SQUIBB CO (US) 2012-05-16 EP disclosed